The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis

Matilde Inglese1, Beatrice Benedetti, Massimo Filippi

  • 1Department of Radiology, New York University School of Medicine, New York, NY, USA.

Insights

Gadolinium-enhanced MRI and brain volume loss in multiple sclerosis (MS) show a mismatch. This review explores reasons for this disconnect and suggests improved in vivo methods for characterizing MS pathology.

Area of Science:

  • Neuroimaging
  • Neurology
  • Pathology

Background:

  • Gadolinium-enhanced MRI and brain volume are used to assess multiple sclerosis (MS) disease activity and damage.
  • Histopathology shows axonal damage correlates with inflammation in MS.
  • In vivo MRI studies report a poor or absent correlation between brain tissue loss and gadolinium enhancement.

Purpose of the Study:

  • To discuss the reasons behind the "inflammation/neurodegeneration mismatch" observed in multiple sclerosis (MS) using in vivo MRI.
  • To propose strategies for improved in vivo characterization of MS pathology.

Main Methods:

  • Review of existing literature on gadolinium-enhanced MRI and brain volume in MS.
  • Analysis of histopathological findings in MS.
  • Discussion of in vivo MRI study limitations.

Main Results:

  • A significant disconnect exists between inflammatory changes (gadolinium enhancement) and neurodegeneration (brain tissue loss) in MS as seen by MRI.
  • This "inflammation/neurodegeneration mismatch" complicates the assessment of disease progression.

Conclusions:

  • Understanding the "inflammation/neurodegeneration mismatch" is crucial for accurate MS assessment.
  • Developing advanced in vivo imaging techniques is necessary to better capture the complex pathology of MS.